For Immediate Release
Chicago, IL – May 20, 2022 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Apple Inc. AAPL, Berkshire Hathaway Inc. (BRK.B), S&P Global Inc. SPGI, Comcast Corp. CMCSA and Cigna Corp. CI
Here are highlights from Thursday’s Analyst Blog:
Top Analyst Reports for Apple, Berkshire Hathaway and S&P Global
The Zacks Research Daily presents the best research output of our analyst team. Today’s Research Daily features new research reports on 16 major stocks, including Apple Inc., Berkshire Hathaway Inc., and S&P Global Inc.. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
You can see all of today’s research reports here >>>
Apple shares are down -18% in the year-to-date period, modestly underperforming the broader market’s -16.2% decline, but they have held up better than the Zacks Tech sector’s -26.7% pullback. While overall sentiment on the entire space remains negative, Apple remains well positioned given momentum in the services and robust performance from iPhone, Mac, Wearables and an expanding App Store ecosystem.
The availability of new Mac Studio and new iPad Air is expected to drive top-line growth. Apple TV+ is gaining recognition due to award-winning shows. This bodes well for the Services segment.
However, Apple did not provide revenue guidance for the third quarter of fiscal 2022. Apple expects COVID-induced supply chain disruptions and industry-wide silicon shortages to hurt the top line by $4-$8 billion. Unfavorable forex conditions along with the absence of Russian revenues are also expected to hurt the top line.
Shares of Berkshire Hathaway have outperformed the Zacks Insurance – Property and Casualty industry over the past year (+6.5% vs. -0.9%). The company is one of the largest property and casualty insurance companies measured by premium volume. Berkshire’s inorganic growth story remains impressive with strategic acquisitions. A strong cash position supports earnings-accretive bolt-on buyouts and indicates the company’s financial flexibility.
Continued insurance business growth fuels increases in float, drive earnings, and generates maximum return on equity. The non-insurance businesses are delivering improved results with increased revenues over the past few years. A sturdy capital level provides the further impetus.
However, exposure to catastrophe loss induces earnings volatility and also affects the property and casualty underwriting results of Berkshire. Huge capital expenditure remains a headwind for the company.
S&P Global shares have declined -11.5% over the past year against the Zacks Business – Information Services industry’s decline of -13.6%. The company remains vulnerable to proceedings, investigations, and inquiries with respect to the ratings provided, leading to legal charges, damages, or fines.
Growth initiatives, higher compensations, and incentives raise the company’s expenses. A decreasing current ratio is not desirable as it indicates that the company may have problems meeting its short-term debt obligations. Partly due to these headwinds, the stock has declined in the past year.
However, The Zacks analyst believes that S&P Global remains well poised to gain from the growing demand for business information services. Buyouts help innovate, increase differentiated content and develop new products. Effective management execution has helped it generate solid cash flow which is utilized for growth initiatives. Dividend payments and share buybacks boost investor’s confidence and positively impact earnings per share.
Other noteworthy reports we are featuring today include Comcast Corp., and Cigna Corp..
Why Haven’t You Looked at Zacks’ Top Stocks?
Our 5 best-performing strategies have blown away the S&P’s impressive +28.8% gain in 2021. Amazingly, they soared +40.3%, +48.2%, +67.6%, +94.4%, and +95.3%. Today you can access their live picks without cost or obligation.
Zacks Investment Research
800-767-3771 ext. 9339
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.
Zacks Names “Single Best Pick to Double”
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.